Skip to main content

Advertisement

Log in

Clinical Significance of Hypophosphatasemia in Children

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Low serum alkaline phosphatase (sALP)—hypophosphatasemia—is a characteristic of hypophosphatasia (HPP), but related to several clinical conditions. Here, we evaluated the frequency, persistency and the etiology of hypophosphatasemia in children. In retrospective analyses of sALP measurements from children, evaluated according to in-house constructed age- and sex-specific reference ranges, patients with no normal sALP measurement (Unresolved hypophosphatasemia) were invited for reanalysis. Prospectively, ALP substrates, pyridoxal-5-phosphate (PLP), and phosphoethanolamine (PEA) were measured in patients with persistent hypophosphatasemia. Radiographs and ALPL gene sequencing for HPP were performed to the cases with elevated PEA and/or PLP. From 130,340 sALP measurements of 93,162 patients, hypophosphatasemia was detected in 1404 samples from 867 patients (0.9%). Among them, 745 had at least one normal sALP values in laboratory records, grouped as transient hypophosphatasemia. 75 out of 122 patients with unresolved hypophosphatasemia could be reanalyzed for sALP, of whom PLP and PEA measurements were required in 37 due to persistent hypophosphatasemia. Both PEA and PLP were elevated in 4 patients, and ALPL gene analysis showed heterozygous mutations in 3 patients and homozygous in 1 patient. Elevated PEA with normal PLP were detected in 3 patients, and one had a heterozygous ALPL mutation. Anemia was the most common diagnosis, and upper respiratory tract infections and chronic diseases were more common in transient and unresolved hypophosphatasemia, respectively. In conclusion, reflected persistent hypophosphatasemia frequency was 1/1552 (0.06%) in this large pediatric cohort and, ALPL gene mutations were detected in 13.5% (5/37) of the studied cases. Although biochemical hypophosphatasemia is not uncommon, clinically significant HPP is rare.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ALP:

Alkaline phosphatase

TNSALP:

Tissue-nonspecific ALP, ALPL gene

HPP:

Hypophosphatasia

PPi:

Inorganic pyrophosphate

PLP:

Pyridoxal-5-phosphate

PEA:

Phosphoethanolamine

Ca:

Calcium

PO4 :

Phosphate

PTH:

Parathyroid hormone

Cre:

Creatinine

S:

Serum

U:

Urine

References

  1. Millán JL (2006) Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Wiley, Weinheim, pp 1–322

    Book  Google Scholar 

  2. Turan S, Topcu B, Gökçe İ, Güran T, Atay Z, Omar Aİ et al (2011) Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets. J Clin Res Pediatr Endocrinol 3:7–11

    Article  Google Scholar 

  3. McKiernan FE, Shrestha LK, Berg RL, Fuehrer J (2014) Acute hypophosphatasemia. Osteoporos Int 25:519–523

    Article  CAS  Google Scholar 

  4. Lum G (1995) Significance of low serum alkaline phosphatase activity in a predominantly adult male population. Clin Chem 41:515–518

    Article  CAS  Google Scholar 

  5. Whyte MP (1994) Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439–461

    CAS  PubMed  Google Scholar 

  6. Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40

    Article  Google Scholar 

  7. Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC et al (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75:229–239

    Article  CAS  Google Scholar 

  8. Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Beurgi S, Sergi C, Ryan L, et al (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T%3eC, p.M226T; c.1112C%3eT, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40:1655–1661.

    Article  CAS  Google Scholar 

  9. Leung EC, Mhanni AA, Reed M, Whyte MP, Landy H, Greenberg CR (2013) Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis. JIMD Rep 11:73–78

    Article  Google Scholar 

  10. Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL et al (2009) Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 10:51

    Article  Google Scholar 

  11. Fallon MD, Teitelbaum SL, Weinstein RS, Goldfischer S, Brown DM, Whyte MP (1984) Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine 63:12–24

    Article  CAS  Google Scholar 

  12. Whyte MP (2013) In: Thakker RV, Whyte MP, Eisman J, Igarashi T (eds) Genetics of bone biology and skeletal disease, 1st edn. Academic Press, New York, pp 337–360

    Chapter  Google Scholar 

  13. Chodirker BN, Evans JA, Seargeant LE, Cheang MS, Greenberg CR (1990) Hyperphosphatemia in infantile hypophosphatasia: implications forcarrier diagnosis and screening. Am J Hum Genet 46:280–285

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904–913

    Article  CAS  Google Scholar 

  15. Silvent J, Gasse B, Mornet E, Sire JY (2014) Molecular evolution of the tissue-nonspecific alkaline phosphatase allows prediction and validation of missense mutations responsible for hypophosphatasia. J Biol Chem 289:24168–24179

    Article  CAS  Google Scholar 

  16. Haliloglu B, Guran T, Atay Z, Abali S, Mornet E, Bereket A et al (2013) Infantile loss of teeth: odontohypophosphatasia or childhood hypophosphatasia. Eur J Pediatr 172:851–853

    Article  Google Scholar 

  17. McKiernan FE, Berg RL, Fuehrer J (2014) Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res 29:1651–1660

    Article  CAS  Google Scholar 

  18. Deeb A, Elfatih A (2018) Could alerting physicians for low alkaline phosphatase levels be helpful in early diagnosis of hypophosphatasia? J Clin Res Pediatr Endocrinol 10:19–24

    Article  Google Scholar 

  19. Saraff V, Narayanan VK, Lawson AJ, Shaw NJ, Preece MA, Högler W (2016) A Diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia. J Pediatr 172(181–186):e1

    Google Scholar 

  20. McKiernan FE, Dong J, Berg RL, Scotty E, Mundt P, Larson L et al (2017) Mutational and biochemical findings in adults with persistent hypophosphatasemia. Osteoporos Int 28:2343–2348

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are thankful to Alexion Pharmaceuticals, Inc for providing fund for ALP substrates and genetic analysis of the patients.

Funding

Alexion Pharmaceuticals, Inc for providing fund for ALP substrates and genetic analysis of the patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serap Turan.

Ethics declarations

Conflict of interest

Rana Bayramli, Tulay Cevlik, Tulay Guran, Zeynep Atay, Serpil Bas, Goncagul Haklar, Abdullah Bereket, and Serap Turan declared that have no conflict of interest to declare.

Human and Animal Rights and Informed Consent

This study was approved by the Marmara University Medical Faculty Research Ethic Committee (Approval number: 09.2015.330), and the consent forms were obtained from all subjects before participating in to the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 88 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayramli, R., Cevlik, T., Guran, T. et al. Clinical Significance of Hypophosphatasemia in Children. Calcif Tissue Int 106, 608–615 (2020). https://doi.org/10.1007/s00223-020-00677-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-020-00677-4

Keywords

Navigation